Ce Li

2.2k total citations
70 papers, 1.7k citations indexed

About

Ce Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ce Li has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 36 papers in Oncology and 27 papers in Cancer Research. Recurrent topics in Ce Li's work include Cancer Immunotherapy and Biomarkers (17 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (13 papers). Ce Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (13 papers). Ce Li collaborates with scholars based in China, United States and Saint Kitts and Nevis. Ce Li's co-authors include Xiujuan Qu, Xiaofang Che, Yunpeng Liu, Yibo Fan, Kezuo Hou, Ling Xu, Ti Wen, Zhi Li, Shuo Wang and Yunpeng Liu and has published in prestigious journals such as Nature Communications, Oncogene and FEBS Letters.

In The Last Decade

Ce Li

68 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ce Li China 24 1.1k 758 624 310 201 70 1.7k
Zhihua Li China 23 919 0.8× 808 1.1× 738 1.2× 254 0.8× 179 0.9× 50 1.6k
Jason R. Pitarresi United States 15 959 0.8× 467 0.6× 830 1.3× 358 1.2× 256 1.3× 36 1.8k
Giulia Bottai Italy 17 1.2k 1.1× 902 1.2× 588 0.9× 230 0.7× 299 1.5× 27 1.9k
Chenghai Zhao China 25 1.1k 0.9× 437 0.6× 541 0.9× 405 1.3× 197 1.0× 61 1.8k
Jianjie Zhu China 25 1.1k 0.9× 713 0.9× 864 1.4× 526 1.7× 437 2.2× 63 2.1k
Selçuk Çolak Netherlands 11 1.0k 0.9× 460 0.6× 761 1.2× 233 0.8× 219 1.1× 13 1.7k
Cailu Song China 23 1.3k 1.1× 968 1.3× 483 0.8× 155 0.5× 253 1.3× 36 1.8k
Zhengtang Chen China 24 835 0.7× 396 0.5× 813 1.3× 345 1.1× 196 1.0× 49 1.6k
Giridhar Mudduluru Germany 22 1.6k 1.4× 1.1k 1.4× 437 0.7× 327 1.1× 126 0.6× 30 2.1k
Yuezhen Deng China 20 1.1k 1.0× 646 0.9× 421 0.7× 330 1.1× 130 0.6× 34 1.8k

Countries citing papers authored by Ce Li

Since Specialization
Citations

This map shows the geographic impact of Ce Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ce Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ce Li more than expected).

Fields of papers citing papers by Ce Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ce Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ce Li. The network helps show where Ce Li may publish in the future.

Co-authorship network of co-authors of Ce Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ce Li. A scholar is included among the top collaborators of Ce Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ce Li. Ce Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Rui, Ce Li, Jingao Li, et al.. (2025). MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway. Journal of Experimental & Clinical Cancer Research. 44(1). 221–221. 1 indexed citations
2.
Che, Xiaofang, Jinyan Wang, Ce Li, et al.. (2025). T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers. Nature Communications. 16(1). 3905–3905. 3 indexed citations
3.
Guo, Jia, Xin Sun, Guowei Pan, et al.. (2023). Pan-cancer immunogenic death analysis identifies key roles of CXCR3 and CCL18 in hepatocellular carcinoma. Genes & Diseases. 11(2). 568–570. 1 indexed citations
4.
Zhao, Jia, Simeng Zhang, Xiaoyu Guo, et al.. (2023). PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis. BMC Cancer. 23(1). 1221–1221. 6 indexed citations
5.
6.
7.
8.
Liu, Yang, et al.. (2021). Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study. Frontiers in Oncology. 11. 603031–603031. 10 indexed citations
9.
Wang, Duo, Xiujuan Qu, Wenqing Lü, et al.. (2021). N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1. Frontiers in Oncology. 11. 681280–681280. 41 indexed citations
10.
Ma, Rui, Xiujuan Qu, Xiaofang Che, et al.. (2021). Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer. OncoTargets and Therapy. Volume 14. 3517–3534. 11 indexed citations
11.
Ma, Rui, Yunpeng Liu, Xiaofang Che, et al.. (2021). Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3. Cancer Letters. 527. 127–139. 23 indexed citations
12.
Song, Na, Ming Bai, Xiaofang Che, et al.. (2020). PD-L1 upregulation accompanied with epithelial–mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells. Medical Oncology. 37(5). 47–47. 9 indexed citations
13.
Zhang, Min, Yibo Fan, Xiaofang Che, et al.. (2020). 5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients. Frontiers in Oncology. 10. 492–492. 46 indexed citations
14.
Yang, Zichang, Xiaonan Shi, Ce Li, et al.. (2018). Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis. Experimental Cell Research. 368(2). 194–201. 50 indexed citations
15.
Xu, Ling, Xiujuan Qu, Xuejun Hu, et al.. (2018). β‐elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts. Cell Biology International. 42(10). 1377–1385. 19 indexed citations
16.
Wen, Ti, Zhenning Wang, Yi Li, et al.. (2017). A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer. Cancer Immunology Research. 5(7). 524–534. 46 indexed citations
17.
Zhang, Ye, Xiujuan Qu, Xiaofang Che, et al.. (2017). miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20. Cell Biology International. 42(5). 506–514. 24 indexed citations
18.
Shi, Xiaonan, Chunlei Zheng, Ce Li, et al.. (2017). 4‐Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition‐mediated HER3/HER4 up‐regulation. Cell Biology International. 42(1). 53–62. 10 indexed citations
19.
Wang, Qian, Ce Li, Zhitu Zhu, et al.. (2015). miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells. Anti-Cancer Drugs. 27(1). 9–16. 28 indexed citations
20.
Li, Heming, Ling Xu, Ce Li, et al.. (2014). Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Molecular Cancer. 13(1). 136–136. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhihua Li Breakdown of academic impact, for papers by Jason R. Pitarresi Breakdown of academic impact, for papers by Giulia Bottai Breakdown of academic impact, for papers by Chenghai Zhao Breakdown of academic impact, for papers by Jianjie Zhu Breakdown of academic impact, for papers by Selçuk Çolak Breakdown of academic impact, for papers by Cailu Song Breakdown of academic impact, for papers by Zhengtang Chen Breakdown of academic impact, for papers by Giridhar Mudduluru Breakdown of academic impact, for papers by Yuezhen Deng
Rankless by CCL
2026